Global TIGIT Therapies Market Growth (Status and Outlook) 2023-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,660	101 Pages	LP Information, Inc.	January, 2023	LPI17670716

Best Price Guarantee
Price	from $3,660
Length	101 Pages
Publisher	LP Information, Inc.
Published Date	January, 2023
SKU	LPI17670716

Global TIGIT Therapies Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “TIGIT Therapies Industry Forecast” looks at past sales and reviews total world TIGIT Therapies sales in 2022, providing a comprehensive analysis by region and market sector of projected TIGIT Therapies sales for 2023 through 2029. With TIGIT Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TIGIT Therapies industry.

This Insight Report provides a comprehensive analysis of the global TIGIT Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TIGIT Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global TIGIT Therapies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TIGIT Therapies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TIGIT Therapies.

The global TIGIT Therapies market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for TIGIT Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for TIGIT Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for TIGIT Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key TIGIT Therapies players cover Roche, Merck, AstraZeneca, Arcus, Astellas, BeiGene, BMS, Junshi Biosciences and Innovent Biologics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of TIGIT Therapies market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Monotherapy
Combination Therapy

Segmentation by application
Cell Carcinoma
Solid Tumor

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Merck
AstraZeneca
Arcus
Astellas
BeiGene
BMS
Junshi Biosciences
Innovent Biologics
Mereo BioPharma
Seattle Genetics
Hengrui Medicine
Compugen

Please note: The report will take approximately 2 business days to prepare and deliver.

*This is a tentative TOC and the final deliverable is subject to change.*

1 Scope of the Report: 1.1 Market Introduction; 1.2 Years Considered; 1.3 Research Objectives; 1.4 Market Research Methodology; 1.5 Research Process and Data Source; 1.6 Economic Indicators; 1.7 Currency Considered; 1.8 Market Estimation Caveats
2 Executive Summary: 2.1 World Market Overview; 2.1.1 Global TIGIT Therapies Market Size 2018-2029; 2.1.2 TIGIT Therapies Market Size CAGR by Region 2018 VS 2022 VS 2029; 2.2 TIGIT Therapies Segment by Type; 2.2.1 Monotherapy; 2.2.2 Combination Therapy; 2.3 TIGIT Therapies Market Size by Type; 2.3.1 TIGIT Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029); 2.3.2 Global TIGIT Therapies Market Size Market Share by Type (2018-2023); 2.4 TIGIT Therapies Segment by Application; 2.4.1 Cell Carcinoma; 2.4.2 Solid Tumor; 2.5 TIGIT Therapies Market Size by Application; 2.5.1 TIGIT Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029); 2.5.2 Global TIGIT Therapies Market Size Market Share by Application (2018-2023)
3 TIGIT Therapies Market Size by Player: 3.1 TIGIT Therapies Market Size Market Share by Players; 3.1.1 Global TIGIT Therapies Revenue by Players (2018-2023); 3.1.2 Global TIGIT Therapies Revenue Market Share by Players (2018-2023); 3.2 Global TIGIT Therapies Key Players Head office and Products Offered; 3.3 Market Concentration Rate Analysis; 3.3.1 Competition Landscape Analysis; 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023); 3.4 New Products and Potential Entrants; 3.5 Mergers & Acquisitions, Expansion
4 TIGIT Therapies by Regions: 4.1 TIGIT Therapies Market Size by Regions (2018-2023); 4.2 Americas TIGIT Therapies Market Size Growth (2018-2023); 4.3 APAC TIGIT Therapies Market Size Growth (2018-2023); 4.4 Europe TIGIT Therapies Market Size Growth (2018-2023); 4.5 Middle East & Africa TIGIT Therapies Market Size Growth (2018-2023)
5 Americas: 5.1 Americas TIGIT Therapies Market Size by Country (2018-2023); 5.2 Americas TIGIT Therapies Market Size by Type (2018-2023); 5.3 Americas TIGIT Therapies Market Size by Application (2018-2023); 5.4 United States; 5.5 Canada; 5.6 Mexico; 5.7 Brazil
6 APAC: 6.1 APAC TIGIT Therapies Market Size by Region (2018-2023); 6.2 APAC TIGIT Therapies Market Size by Type (2018-2023); 6.3 APAC TIGIT Therapies Market Size by Application (2018-2023); 6.4 China; 6.5 Japan; 6.6 Korea; 6.7 Southeast Asia; 6.8 India; 6.9 Australia
7 Europe: 7.1 Europe TIGIT Therapies by Country (2018-2023); 7.2 Europe TIGIT Therapies Market Size by Type (2018-2023); 7.3 Europe TIGIT Therapies Market Size by Application (2018-2023); 7.4 Germany; 7.5 France; 7.6 UK; 7.7 Italy; 7.8 Russia
8 Middle East & Africa: 8.1 Middle East & Africa TIGIT Therapies by Region (2018-2023); 8.2 Middle East & Africa TIGIT Therapies Market Size by Type (2018-2023); 8.3 Middle East & Africa TIGIT Therapies Market Size by Application (2018-2023); 8.4 Egypt; 8.5 South Africa; 8.6 Israel; 8.7 Turkey; 8.8 GCC Countries
9 Market Drivers, Challenges and Trends: 9.1 Market Drivers & Growth Opportunities; 9.2 Market Challenges & Risks; 9.3 Industry Trends
10 Global TIGIT Therapies Market Forecast: 10.1 Global TIGIT Therapies Forecast by Regions (2024-2029); 10.1.1 Global TIGIT Therapies Forecast by Regions (2024-2029); 10.1.2 Americas TIGIT Therapies Forecast; 10.1.3 APAC TIGIT Therapies Forecast; 10.1.4 Europe TIGIT Therapies Forecast; 10.1.5 Middle East & Africa TIGIT Therapies Forecast; 10.2 Americas TIGIT Therapies Forecast by Country (2024-2029); 10.2.1 United States TIGIT Therapies Market Forecast; 10.2.2 Canada TIGIT Therapies Market Forecast; 10.2.3 Mexico TIGIT Therapies Market Forecast; 10.2.4 Brazil TIGIT Therapies Market Forecast; 10.3 APAC TIGIT Therapies Forecast by Region (2024-2029); 10.3.1 China TIGIT Therapies Market Forecast; 10.3.2 Japan TIGIT Therapies Market Forecast; 10.3.3 Korea TIGIT Therapies Market Forecast; 10.3.4 Southeast Asia TIGIT Therapies Market Forecast; 10.3.5 India TIGIT Therapies Market Forecast; 10.3.6 Australia TIGIT Therapies Market Forecast; 10.4 Europe TIGIT Therapies Forecast by Country (2024-2029); 10.4.1 Germany TIGIT Therapies Market Forecast; 10.4.2 France TIGIT Therapies Market Forecast; 10.4.3 UK TIGIT Therapies Market Forecast; 10.4.4 Italy TIGIT Therapies Market Forecast; 10.4.5 Russia TIGIT Therapies Market Forecast; 10.5 Middle East & Africa TIGIT Therapies Forecast by Region (2024-2029); 10.5.1 Egypt TIGIT Therapies Market Forecast; 10.5.2 South Africa TIGIT Therapies Market Forecast; 10.5.3 Israel TIGIT Therapies Market Forecast; 10.5.4 Turkey TIGIT Therapies Market Forecast; 10.5.5 GCC Countries TIGIT Therapies Market Forecast; 10.6 Global TIGIT Therapies Forecast by Type (2024-2029); 10.7 Global TIGIT Therapies Forecast by Application (2024-2029)
11 Key Players Analysis: 11.1 Roche; 11.1.1 Roche Company Information; 11.1.2 Roche TIGIT Therapies Product Offered; 11.1.3 Roche TIGIT Therapies Revenue, Gross Margin and Market Share (2018-2023); 11.1.4 Roche Main Business Overview; 11.1.5 Roche Latest Developments; 11.2 Merck; 11.2.1 Merck Company Information; 11.2.2 Merck TIGIT Therapies Product Offered; 11.2.3 Merck TIGIT Therapies Revenue, Gross Margin and Market Share (2018-2023); 11.2.4 Merck Main Business Overview; 11.2.5 Merck Latest Developments; 11.3 AstraZeneca; 11.3.1 AstraZeneca Company Information; 11.3.2 AstraZeneca TIGIT Therapies Product Offered; 11.3.3 AstraZeneca TIGIT Therapies Revenue, Gross Margin and Market Share (2018-2023); 11.3.4 AstraZeneca Main Business Overview; 11.3.5 AstraZeneca Latest Developments; 11.4 Arcus; 11.4.1 Arcus Company Information; 11.4.2 Arcus TIGIT Therapies Product Offered; 11.4.3 Arcus TIGIT Therapies Revenue, Gross Margin and Market Share (2018-2023); 11.4.4 Arcus Main Business Overview; 11.4.5 Arcus Latest Developments; 11.5 Astellas; 11.5.1 Astellas Company Information; 11.5.2 Astellas TIGIT Therapies Product Offered; 11.5.3 Astellas TIGIT Therapies Revenue, Gross Margin and Market Share (2018-2023); 11.5.4 Astellas Main Business Overview; 11.5.5 Astellas Latest Developments; 11.6 BeiGene; 11.6.1 BeiGene Company Information; 11.6.2 BeiGene TIGIT Therapies Product Offered; 11.6.3 BeiGene TIGIT Therapies Revenue, Gross Margin and Market Share (2018-2023); 11.6.4 BeiGene Main Business Overview; 11.6.5 BeiGene Latest Developments; 11.7 BMS; 11.7.1 BMS Company Information; 11.7.2 BMS TIGIT Therapies Product Offered; 11.7.3 BMS TIGIT Therapies Revenue, Gross Margin and Market Share (2018-2023); 11.7.4 BMS Main Business Overview; 11.7.5 BMS Latest Developments; 11.8 Junshi Biosciences; 11.8.1 Junshi Biosciences Company Information; 11.8.2 Junshi Biosciences TIGIT Therapies Product Offered; 11.8.3 Junshi Biosciences TIGIT Therapies Revenue, Gross Margin and Market Share (2018-2023); 11.8.4 Junshi Biosciences Main Business Overview; 11.8.5 Junshi Biosciences Latest Developments; 11.9 Innovent Biologics; 11.9.1 Innovent Biologics Company Information; 11.9.2 Innovent Biologics TIGIT Therapies Product Offered; 11.9.3 Innovent Biologics TIGIT Therapies Revenue, Gross Margin and Market Share (2018-2023); 11.9.4 Innovent Biologics Main Business Overview; 11.9.5 Innovent Biologics Latest Developments; 11.10 Mereo BioPharma; 11.10.1 Mereo BioPharma Company Information; 11.10.2 Mereo BioPharma TIGIT Therapies Product Offered; 11.10.3 Mereo BioPharma TIGIT Therapies Revenue, Gross Margin and Market Share (2018-2023); 11.10.4 Mereo BioPharma Main Business Overview; 11.10.5 Mereo BioPharma Latest Developments; 11.11 Seattle Genetics; 11.11.1 Seattle Genetics Company Information; 11.11.2 Seattle Genetics TIGIT Therapies Product Offered; 11.11.3 Seattle Genetics TIGIT Therapies Revenue, Gross Margin and Market Share (2018-2023); 11.11.4 Seattle Genetics Main Business Overview; 11.11.5 Seattle Genetics Latest Developments; 11.12 Hengrui Medicine; 11.12.1 Hengrui Medicine Company Information; 11.12.2 Hengrui Medicine TIGIT Therapies Product Offered; 11.12.3 Hengrui Medicine TIGIT Therapies Revenue, Gross Margin and Market Share (2018-2023); 11.12.4 Hengrui Medicine Main Business Overview; 11.12.5 Hengrui Medicine Latest Developments; 11.13 Compugen; 11.13.1 Compugen Company Information; 11.13.2 Compugen TIGIT Therapies Product Offered; 11.13.3 Compugen TIGIT Therapies Revenue, Gross Margin and Market Share (2018-2023); 11.13.4 Compugen Main Business Overview; 11.13.5 Compugen Latest Developments
12 Research Findings and Conclusion